At the Tallahassee Memorial Cancer Center, our experienced team can treat many types of cancers and blood disorders.
Some of the more common types of cancer we treat:
- Breast Cancer
- Colon Cancer
- Hodgkin’s Lymphoma
- Lung Cancer
- Non-Hodgkin’s Lymphoma
- Prostate Cancer
- Gynecologic Cancer
The Tallahassee Memorial Cancer Center offers the most robust and advanced programs in the region, including:
Led by an expert team of board-certified medical oncologists, Tallahassee Memorial provides chemotherapy and hormone therapy to patients in the Angie Deeb Cancer Unit and in a special infusion area on the second floor of the Cancer Center.
Learn more about Chemotherapy
Early detection is your first line of defense against cancer. That’s why we offer a variety of advanced screening services to help diagnose pre-cancer and cancer.
Learn more about Diagnostic Services
DigniCap Scalp Cooling System
Approved by the FDA, DigniCap® minimizes hair loss from certain chemotherapy treatments for women and men with solid tumors such as those associated with breast, ovarian, uterine, prostate and other tissues.
Learn more about DigniCap
Cancer Genetic Services
It is crucial to identify families with a hereditary predisposition to cancer as they can then take steps to prevent or diagnose in early stages particular cancers enhancing long term-survival.
Learn more about Cancer Genetic Services
The Tallahassee Memorial Cancer Center offers special expertise in the area of hematology. These physicians also treat malignant blood disorders, as well as benign blood disorders, often proving life threatening for patients.
Learn more about Hematology
Our experienced radiation oncology team offers the most advanced radiation therapy program in the Big Bend region. About half of all cancer patients receive some type of radiation therapy during the course of their treatment.
Learn more about Radiation Therapy
Surgical oncology is a specialty that focuses on the surgical treatment of a variety of tumors, the most common being breast cancer, colorectal cancer, melanoma and endocrine tumors.
Learn more about Surgical Oncology
A clinical trials program is an essential part of a true cancer center. All of the current treatments for oncology patients today have been developed from yesterday’s trials. Our program enables patients in our community to receive potential direct benefit of new drugs and treatment pathways while sleeping in their own bed at night, but also indirectly builds the science for future patients who may be their loved ones.
Breast Cancer Trials
NRG-BR003: For newly diagnosed patients with Triple Negative Breast Cancer, looking at the addition of Carboplatin to the current standard treatment, to see if it will keep the cancer from growing or coming back as quickly. Learn More.
S1418/BR006: For patients diagnosed with Triple Negative Breast Cancer who have received neoadjuvant treatment (chemotherapy before surgery), and whose cancer has at least partly survived that treatment. This study is being done to see the effect of Pembrolizumab, a type of immunotherapy, in treating patients with this diagnosis. Learn More.
POL6326-009: This trial is looking at the combination of Balixafortide and Eribulin vs Eribulin alone, in patients with HER 2 negative, locally recurrent or metastatic breast cancer. Patients must have already received 1 line of therapy, and no more than 5 lines of therapy. Learn More.
I3Y-MC-JPCU: A trial using Abemaciclib in combination with Fulvestrant, compared to chemotherapy, in women with hormone positive, HER 2 negative metastatic breast cancer. Learn More.
A011401/BWEL: A study that will evaluate the benefit of weight loss and the recurrence of breast cancer, after surgery and routine postoperative therapy, in overweight women with early stage HER 2 negative breast cancer. Learn More.
We are now a participant in the nationwide Cancer Experience Registry. This is an online initiative to understand the experiences of those impacted by a cancer diagnosis. The Cancer Experience Registry is open to anyone who has been diagnosed with cancer—as well as those relatives or friends who assist with their care. The information from the Cancer Experience Registry helps us identify the issues that are more important to you and use that information to fill the gaps in care and deliver improved services to the cancer community. People impacted by cancer—patients and caregivers—are experts in their needs and experiences. The Cancer Experience Registry puts the patient experience and patient voice at the center of the cancer conversation. Register for this study.
Please contact us at one of the following locations or by using the contact form below.
Contact Our Cancer Team
Have questions for our Cancer team? Use our contact form to contact us.
Accredited since 1951, by the American College of Surgeon’s Commission on Cancer, the Tallahassee Memorial Cancer Center is the longest continuously accredited comprehensive community hospital cancer program in the State of Florida. Additionally, the Cancer Center is Accredited by the National Accreditation Program for Breast Centers.
We're pleased to present the Tallahassee Memorial Cancer Center Annual Reports. Each year, as a service to our community, we have included a recap of information for your reference, as it relates to our facility and quality oncology care.
2019 Cancer Center Annual Report
2018 Cancer Center Annual Report
2017 Cancer Center Annual Report
2016 Cancer Center Annual Report
2015 Cancer Center Annual Report
2014 Cancer Center Annual Report